A company with headquarters in Germany, working with the best scientists in their fields. sajo is a research-driven enterprise that develops groundbreaking compounds with highly active antiviral activity.

Infectious diseases are spreading at an increasing pace. For this reason, available medication is scarce compared to the number of pathogens. Numerous viral and bacterial diseases cannot be treated yet, with numbers growing steadily. Worldwide, mankind is facing a major problem. Furthermore, adding to this challenge, is the fact that life stock animals in agriculture are targets for pathogens, too, resulting in billions of dollars of revenues lost each year.

sajo’s Research & Development now is offering new avenues for treatment and especially for prevention of infectious diseases using newly developed approaches and a breakthrough technology to screen for drugs and drug targets of a new dimension. Using this new key technology, sajo opens up new sources of antivirals with high activities against infectious diseases. Complementing this approach, sajo also develops diagnostic and research tools around the newly identified drugs and drug targets.

Intellectually super-charged inventions and developments across several scientific disciplines are key to sajo’s entirely new approaches.

Within the market, sajo is located in the field of preclinical research and development: screening, drug isolation, drug synthesis and development. Once identified, these new, highly active, compounds will be tested in vitro and in vivo for their potential to bring a radical solution to upcoming disease threats.

If you are interested in pursuing these goals together with us, please contact us.